SiVEC Biotechnologies
Fort Collins, US · Founded 2022 · Delaware corporation
Biotech
Founders & leadership
LL
Lyndsey LinkeExecutive Officer, Director
SH
Sibylle HauserDirector
DM
Darcy MoraExecutive Officer, Director
RA
Richard A. Freed IIIDirector
DS
David SherrisDirector
Reported raises · per SEC filings
Form D private placements▶$3.3MraisedSep 2025 · 3 investors · BiotechnologyRule 506(b)
▶$3.3MraisedSep 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SherrisDirector
- Darcy MoraExecutive Officer, Director
- Lyndsey LinkeExecutive Officer, Director
- Richard A. Freed IIIDirector
- Sibylle HauserDirector
- Offering amount
- $5.8M
- Amount sold
- $3.3M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $286.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $293.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.